The global empty capsule market is projected to reach USD 2,956.6 million in 2024, with sales expected to expand at an 8% ...
Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s ...
Homeland Security and the Whatcom Gang and Drug Task Force arrested a Canadian man who smuggled nearly 13,000 doses of MDMA ...
Bottles of two medications that prevent the body's rejection of transplanted organs were recalled because the capsules may be ...
Astellas Pharma US, Inc. has issued a recall for one lot of PROGRAF 0.5mg (tacrolimus) and one lot of ASTAGRAF XL 0.5mg ...
Astellas Pharma and Endo subsidiary Endo USA issued voluntary recalls for products they manufacture over concerns of empty tablets and unapproved ingredients, respectively. | Astellas Pharma and Endo ...
Pharmaceutical company Astellas Pharma announced two urgent recalls for vital immunosuppressive drugs, Prograf and Astagraf XL, that are used to prevent organ rejection in transplant recipients.
Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.